32 related articles for article (PubMed ID: 21171262)
1. Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue.
Wu ZL; Yuan Y; Geng H; Xia SJ
Asian J Androl; 2012 Mar; 14(2):316-9. PubMed ID: 22157983
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of the expressions of 4-HNE and GPC5 with the progression of prostate cancer].
Song Q; Yan HZ; Wang R; Zhang ZY; Zuo QJ; Song X
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):19-24. PubMed ID: 37846827
[TBL] [Abstract][Full Text] [Related]
3. Differential research of inflammatory and related mediators in BPH, histological prostatitis and PCa.
Huang TR; Wang GC; Zhang HM; Peng B
Andrologia; 2018 Feb; ():. PubMed ID: 29441606
[TBL] [Abstract][Full Text] [Related]
4. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy.
Lemos G; Fernandes CMAS; Silva FH; Calmasini FB
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):230-238. PubMed ID: 38297152
[TBL] [Abstract][Full Text] [Related]
5. MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer.
Khan MA; Acharya S; Anand S; Sameeta F; Pramanik P; Keel C; Singh S; Carter JE; Dasgupta S; Singh AP
iScience; 2023 Dec; 26(12):108487. PubMed ID: 38089573
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate hub genes correlated with the pathogenesis, diagnosis, and prognosis of prostate cancer by integrated bioinformatics analysis.
Wei T; Liang Y; Anderson C; Zhang M; Zhu N; Xie J
Transl Cancer Res; 2022 Oct; 11(10):3548-3571. PubMed ID: 36388030
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data.
Chen C; Zhang LG; Liu J; Han H; Chen N; Yao AL; Kang SS; Gao WX; Shen H; Zhang LJ; Li YP; Cao FH; Li ZG
Onco Targets Ther; 2016; 9():1545-57. PubMed ID: 27051295
[TBL] [Abstract][Full Text] [Related]
8. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of human androgens and prostatic diseases.
Novelli G; Margiotti K; Sangiuolo F; Reichardt JK
Pharmacogenomics; 2001 Feb; 2(1):65-72. PubMed ID: 11258198
[TBL] [Abstract][Full Text] [Related]
10. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
Zhu LY; Zhong KB; Lu SX; He LY
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
12. [Expression of sexual hormon receptors in prostatic cancer tissues].
Ding T; Che WJ; Chen TJ
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):50-2, 56. PubMed ID: 16483160
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
